(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202209 | 202109 | % Var | 202209 | 202109 | % Var | 202203 | 202103 | % Var | |
| Sales | 19.17 | 19.51 | -1.74 | 37.55 | 38.01 | -1.21 | 69.74 | 61.59 | 13.23 |
| Other Income | 0.45 | 0.29 | 55.17 | 0.86 | 0.70 | 22.86 | 1.71 | 1.91 | -10.47 |
| PBIDT | 2.12 | 2.06 | 2.91 | 3.99 | 3.87 | 3.10 | 7.57 | 5.22 | 45.02 |
| Interest | 0.13 | 0.19 | -31.58 | 0.25 | 0.39 | -35.90 | 0.76 | 0.87 | -12.64 |
| PBDT | 1.99 | 1.87 | 6.42 | 3.74 | 3.48 | 7.47 | 6.81 | 4.35 | 56.55 |
| Depreciation | 0.32 | 0.50 | -36.00 | 0.64 | 1.00 | -36.00 | 2.01 | 1.91 | 5.24 |
| PBT | 1.67 | 1.37 | 21.90 | 3.10 | 2.48 | 25.00 | 4.80 | 2.44 | 96.72 |
| TAX | 0.50 | 0.37 | 35.14 | 0.83 | 0.65 | 27.69 | 1.41 | 0.38 | 271.05 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.09 | -0.40 | -77.50 |
| PAT | 1.17 | 1.00 | 17.00 | 2.27 | 1.83 | 24.04 | 3.39 | 2.06 | 64.56 |
| Equity | 25.19 | 35.45 | -28.94 | 25.19 | 45.71 | -44.89 | 35.45 | 35.45 | 0.00 |
| PBIDTM(%) | 11.06 | 10.56 | 4.74 | 10.63 | 10.18 | 4.36 | 10.85 | 8.48 | 28.07 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1867.80 |
| Dr. Reddys Lab | 1301.30 |
| Cipla | 1433.10 |
| Zydus Lifesciences | 1112.10 |
| Lupin | 2356.55 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: